The experience of colleagues physicians in application of phago-products will help to choose the optimal prevention and treatment regimen for a particular infectious disease
The treatment of cystitis using the bacteriophages is reasonable with acute as well as chronic forms of disease, especially considering inefficiency of traditional uroanticeptics and antibiotics. The widespread causative agents of infectious cystitis are destroyed by the bacteriophages contained in Pyophage®.
The agents of human opportunistic pathogenic flora often develop multi-drug resistance to antibiotics. Using the bacteriophages in treatment of pyoinflammatory diseases of ear, nose and throat allows not only eliminating the infection, but also stimulating the own immune responses of the body.
In treatment of the stomatitis it is crucial to provide disinfection of the oral cavity, eliminate the pain and inflammation, and prevent the spreading of infection. For prevention and treatment of stomatitis bacteriophage products are applied, in particular Pyophage®. Bacteriophages lyze the most common agents of pyoinflammatory diseases of oral cavity.
Antibiotics are prescribed for treatment of enteric infections in the most severe cases. Typically the so called enteric antiseptics are used – the products acting only in the intestinal lumen and not always efficient. Bacteriophages are an alternative to the traditional antibacterial products.
Bacteriophages, in particular Pyophage ® product, are used for prevention and treatment of pyogenic septic complications of wound processes. The product has a bactericidal effect on a series of common pathogens, including antibiotic resistant ones.
To eliminate the opportunistic pathogenic microflora it is reasonable to apply the corresponding bacteriophages. The phago-products are highly specific – they kill only the definite bacteria without affecting the useful microflora.
Don't worry: Your personal data are safe
Phage therapy - is a field of medical microbiology, which is now actively developing and is the subject of numerous scientific and clinical studies, the "hot topic" of medical forums and congresses.
The purpose of this study is investigation of the sensitivity of clinical isolates of Staphylococcus aureus, including methicillin-resistant strains, to bacteriophage drugs and determination of possibility of using this agent for the treatment of staphylococcal infections
This review summarizes recent phage therapy clinical trials and patient cases and outlines the fundamentals behind phage treatment strategies under development, mainly through bench-to-bedside approaches
The decrease of bacterial growth and the covalent binding of synthetic antibodies to viruses - both goals can be achieved by bacteriophages
